Sign up to save your podcasts
Or
Share Personalized treatment of RET-altered thyroid cancers
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Personalized treatment of RET-altered thyroid cancers
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
- Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies/?_ga=2.29473663.1151443503.1654521477-1202917360.1651662103
View all episodes
By touchpodcasttouchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers
The experts
- Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from from Blueprint Medicines and Genentech, a member of the Roche Group. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/personalized-treatment-of-ret-altered-thyroid-cancers-what-is-the-value-of-biomarker-testing-and-targeted-therapies/?_ga=2.29473663.1151443503.1654521477-1202917360.1651662103